1. Stryker Q2 net sales jump 16.8% to $2.8B: 9 key notes

Written by Laura Dyrda | Friday, 22 July 2016 00:00
Stryker reported net sales growth in the second quarter of 2016.
Here are 16 key notes on orthopedic and spine device companies over the past week.
American Medical Association, American College of Cardiology and almost 100 other national and state medical societies are supporting a Senate bill that would not require drug and device manufactures to report payments they made to physicians for receiving continuing medical education sessions, medical journal or textbooks, according to STAT.
Pan Medical has just launched the InterV Micro.
DePuy Synthes and Stryker lead the Australian bone graft substitutes market, according to analysis by iData Research.
MedTech reported financial results for its fourth quarter and full year ended June 30, 2016, on the heels of Zimmer Biomet announcing plans to acquire majority stake in the company.
Medtronic received the first-ever FDA clearance for cement-augmented pedicle screws in the CD Horizon Fenestrated Screws.
Johnson & Johnson reported sales growth for the DePuy Synthes orthopedics line in the second quarter.
Here are six highlights from Medtronic's recent investor day, according to a Seeking Alpha report.
Zimmer Biomet and Indo UK Institutes of Health announced plans for a multi-year collaboration.

11. Arthrex to create 560 jobs in Florida: 4 takeaways

Written by Anuja Vaidya | Wednesday, 20 July 2016 00:00
Arthrex is expanding to create 560 jobs at its corporate campus in Naples, Fla., according to a Naples Daily News report.
A Proceedings of the National Academy of Sciences study shows that patient's stem cells could be used to grow new cartilage in the shape of a hip joint, which may serve as an alternative to hip replacement surgery, according to a Medical News Today report.
The expansive fluoroscopy and Mobile C-arms market is expected to increase at a compound annual growth rate of 2.8 percent between 2015 and 2020, according to medGadget.
By 2020, the U.S. medical device outsourcing market is expected to reach $27.8 billion, according to a Grand View Research report.
Twenty equity analysts who rate Medtronic stock have given it an average target price of $87.83, according to Fortune Review and Insights.
InVivo Therapeutics added Ben Taub Hospital in Houston as a clinical site for the INSPIRE study.
IlluminOss Medical has completed enrollment in its first U.S. clinical trial for its IlluminOss System.
Data from two new clinical studies on the Mazor robotic technology were presented at the International Meeting on Advanced Spine Techniques” in Washington, DC.
Zimmer Biomet plans to acquire majority stake in MedTech, a France-based company focused on the ROSA Robotic System for brain and spine surgery, according to a Nasdaq report.

20. Life Spine revenues up 50% in Q2 — 4 highlights

Written by Mary Rechtoris | Tuesday, 19 July 2016 00:00
Huntley, Ill.-based Life Spine reported significant financial growth in the second quarter of 2016.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 312

Top 40 Articles from the Past 6 Months